“My stance on this issue has been clear. I remain committed to combatting the growing public health and safety threat marijuana poses.”
By Zach Wendling, Nebraska Examiner
After the Trump administration federally downgraded medical marijuana to a less dangerous classification of drug on Thursday, Nebraska federal and state representatives remained largely noncommittal.
Advocates, meanwhile, said the move means the “last prohibitionist talking point has collapsed.”
“Nebraska officials can still oppose medical cannabis out of stubbornness, but they can no longer hide behind the claim that the federal government says cannabis has no accepted medical use. That excuse is gone,” said John Cartier, attorney general for the Omaha Tribe of Nebraska, which is moving forward with its own medical cannabis program, separate from the State of Nebraska.
On Thursday, acting U.S. Attorney General Todd Blanche immediately downgraded state-licensed and U.S. Food and Drug Administration-approved marijuana products to Schedule III.
Schedule I drugs, such as heroin, LSD, ecstasy and peyote, are drugs the federal government has classified with a high likelihood of abuse and no currently accepted medical value. Schedule III drugs are defined as those with moderate to low potential for physical and psychological dependence, such as Tylenol with codeine, ketamine
Read full article on Marijuana Moment
